AMERICAN HEALTHCARE REIT INC Stock Price, News & Analysis

American Healthcare REIT (NYSE: AHR) has announced the dates for its third quarter 2024 earnings release and conference call. The company will issue its earnings release on Tuesday, November 12, 2024, after the close of trading. A public conference call with a simultaneous webcast is scheduled for Wednesday, November 13, 2024, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time.

During the conference call, company executives will review third quarter 2024 results, discuss recent events, and conduct a question-and-answer session. Investors can join via webcast or telephone, with pre-registration required for the latter. A digital replay of the call and the full earnings report with supplemental data will be available on the company's Investor Relations website shortly after the call concludes.

American Healthcare REIT, Inc. (NYSE: AHR) has acquired the remaining 24% minority membership interest in Trilogy REIT Holdings, for approximately $258 million. This acquisition makes AHR the sole owner of Trilogy Holdings and its Integrated Senior Health Campuses (ISHC). The transaction was funded using net proceeds from AHR's recent equity offering, with the remaining funds used to repay approximately $194.0 million of debt on its lines of credit.

Based on Q2 2024 results, assuming the acquisition had closed at the beginning of that period, the ISHC segment would have comprised about 55.3% of AHR's total portfolio cash net operating income. Danny Prosky, AHR's President and CEO, stated that the acquisition was completed in an accretive and leverage neutral manner, potentially leading to further accretion and increased borrowing capacity.

American Healthcare REIT (NYSE: AHR) has priced an upsized public offering of 17,400,000 shares of common stock at $23.55 per share. The company has granted underwriters a 30-day option to purchase up to an additional 2,610,000 shares. Net proceeds will be used to acquire the remaining 24% minority interest in Trilogy Holdings, and to repay debt on existing credit lines. The offering is expected to close on September 20, 2024. BofA Securities, Morgan Stanley, and KeyBanc Capital Markets are acting as joint book-running managers, with several other firms in supporting roles. The offering is being made pursuant to the company's effective shelf registration statement filed with the SEC.

American Healthcare REIT (NYSE: AHR) has announced a primary public offering of 14,500,000 shares of its common stock. The company plans to grant underwriters a 30-day option to purchase up to an additional 2,175,000 shares. Proceeds will be used to acquire its joint venture partner's 24% minority stake in Trilogy Holdings, and to repay debt on existing lines of credit. BofA Securities, Morgan Stanley, and KeyBanc Capital Markets are acting as joint book-running managers for the offering. The stock issuance is being made under the company's effective shelf registration statement filed with the SEC. A preliminary prospectus supplement and accompanying prospectus will be available from the underwriters or the SEC's EDGAR database.

American Healthcare REIT (NYSE: AHR) has announced a quarterly distribution of $0.25 per share for the third quarter of 2024. This distribution will be paid in cash on October 18, 2024 to shareholders of record as of September 20, 2024. The announcement demonstrates the company's commitment to providing regular returns to its investors, which is typical for Real Estate Investment Trusts (REITs). This distribution maintains consistency with previous quarters, suggesting stability in the company's cash flow and dividend policy.

American Healthcare REIT (NYSE: AHR) has announced its participation in the BofA Securities 2024 Global Real Estate Conference. Key executives, including CFO Brian Peay, COO Gabe Willhite, CIO Stefan Oh, and VP of Investor Relations & Finance Alan Peterson, will take part in a roundtable presentation on Thursday, September 12, 2024, from 10:20 a.m. to 10:55 a.m. Eastern Time.

The presentation will be broadcast live via webcast, with a replay available for up to one year following the conference. This event provides an opportunity for investors and analysts to gain insights into AHR's strategies and performance in the healthcare real estate sector.

Shepherd Smith Edwards and Kantas is offering free consultations to American Healthcare REIT (NYSE:AHR) investors following a 3% share price drop on August 6, 2024. AHR, formed from the merger of Griffin-American Healthcare REIT III, IV, and American Healthcare Investors, debuted on the NYSE in February 2024 with a 56 million share IPO at $12/share. Legacy investors, however, had purchased 66 million shares at $40/share.

The REIT's portfolio, valued at $4.6B in September 2023, includes medical office buildings, skilled nursing facilities, and hospitals. Concerns have arisen about potential broker misconduct in recommending AHR, given its high commissions and fees. Investors may explore legal options for recovery, as the firm has previously helped recoup millions for clients affected by negligent stockbrokers.

American Healthcare REIT (NYSE: AHR) reported strong Q2 2024 results and increased its full-year 2024 guidance. Key highlights include:

• GAAP net income of $2.9 million, up from a $11.9 million loss in Q2 2023
• Normalized FFO of $0.33 per diluted share
• Total portfolio Same-Store NOI growth of 15.7%, driven by strong performance in SHOP (49.1%) and ISHC (24.1%) segments
• Increased full-year 2024 Same-Store NOI growth guidance to 12-14% from 5-7%
• Raised NFFO guidance to $1.23-$1.27 per share from $1.18-$1.24
• Improved Net-Debt-to-Adjusted EBITDA from 6.4x to 5.9x

Management cited strong demand for healthcare real estate and expects elevated Same-Store NOI growth to continue due to the demand-supply imbalance in long-term care.

American Healthcare REIT (NYSE: AHR) announced it will release its second quarter 2024 earnings on August 5, 2024, after market close. The company will hold a public conference call and webcast on August 6, 2024, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time, where executives will review the Q2 2024 results, discuss recent events, and conduct a Q&A session. The webcast can be accessed via a provided link, and a digital replay will be available on the company's Investor Relations website shortly after the call. The full earnings report and supplemental data will be posted on the Investor Relations section on August 5, 2024.